WO2002048316A1 - Method for in vitro culture of ovarian follicles - Google Patents
Method for in vitro culture of ovarian follicles Download PDFInfo
- Publication number
- WO2002048316A1 WO2002048316A1 PCT/BE2001/000209 BE0100209W WO0248316A1 WO 2002048316 A1 WO2002048316 A1 WO 2002048316A1 BE 0100209 W BE0100209 W BE 0100209W WO 0248316 A1 WO0248316 A1 WO 0248316A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- follicle
- culture
- follicles
- oocyte
- medium
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 47
- 210000002394 ovarian follicle Anatomy 0.000 title claims abstract description 15
- 238000000338 in vitro Methods 0.000 title claims abstract description 11
- 210000000287 oocyte Anatomy 0.000 claims abstract description 38
- 241000124008 Mammalia Species 0.000 claims abstract description 13
- 210000001672 ovary Anatomy 0.000 claims abstract description 13
- 210000003684 theca cell Anatomy 0.000 claims abstract description 9
- 210000002503 granulosa cell Anatomy 0.000 claims abstract description 5
- 230000001737 promoting effect Effects 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims description 11
- 230000004069 differentiation Effects 0.000 claims description 10
- 230000035800 maturation Effects 0.000 claims description 9
- 238000004458 analytical method Methods 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- 238000010200 validation analysis Methods 0.000 claims description 6
- 230000023715 cellular developmental process Effects 0.000 claims description 3
- 238000002513 implantation Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 210000000349 chromosome Anatomy 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 210000003463 organelle Anatomy 0.000 claims description 2
- 230000035755 proliferation Effects 0.000 claims description 2
- 238000010186 staining Methods 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- 238000004166 bioassay Methods 0.000 abstract description 2
- 239000002609 medium Substances 0.000 description 26
- 230000002611 ovarian Effects 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 238000011161 development Methods 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000003744 In vitro fertilisation Methods 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 210000004602 germ cell Anatomy 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000016087 ovulation Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 2
- 108010011942 LH Receptors Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 229930012538 Paclitaxel Natural products 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 230000034004 oogenesis Effects 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 229960001592 paclitaxel Drugs 0.000 description 2
- 210000004508 polar body Anatomy 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000023108 LH Receptors Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000029803 blastocyst development Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229960004407 chorionic gonadotrophin Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000001771 cumulus cell Anatomy 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012909 foetal bovine serum Substances 0.000 description 1
- 210000004186 follicle cell Anatomy 0.000 description 1
- 229940028334 follicle stimulating hormone Drugs 0.000 description 1
- 239000000659 freezing mixture Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 150000002634 lipophilic molecules Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 102000014650 luteinizing hormone receptor activity proteins Human genes 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000009806 oophorectomy Methods 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 210000004340 zona pellucida Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0609—Oocytes, oogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/24—Genital tract cells, non-germinal cells from gonads
- C12N2502/243—Cells of the female genital tract, non-germinal ovarian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Mushroom Cultivation (AREA)
Abstract
Description
Claims
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK01994564T DK1341901T3 (en) | 2000-12-13 | 2001-12-11 | Method for in vitro culture of ovarian follicles |
NZ525925A NZ525925A (en) | 2000-12-13 | 2001-12-11 | Method for in vitro culture of ovarian follicles using an attachment promoting second medium which is oil free |
US10/450,695 US20040053407A1 (en) | 2000-12-12 | 2001-12-11 | Method for in vitro culture of ovarian follicles |
DE60135869T DE60135869D1 (en) | 2000-12-13 | 2001-12-11 | PROCEDURE FOR THE IN VITRO CULTURE OF OVARIAL FOLLICLES |
AU2466902A AU2466902A (en) | 2000-12-13 | 2001-12-11 | Method for in vitro culture of ovarian follicles |
HU0302600A HUP0302600A3 (en) | 2000-12-13 | 2001-12-11 | Method for in vitro culture of ovarian follicles |
KR10-2003-7007959A KR20030081350A (en) | 2000-12-13 | 2001-12-11 | Method for in vitro culture of ovarian follicles |
CA002429401A CA2429401A1 (en) | 2000-12-13 | 2001-12-11 | Method for in vitro culture of ovarian follicles |
EP01994564A EP1341901B8 (en) | 2000-12-13 | 2001-12-11 | Method for in vitro culture of ovarian follicles |
PL01362063A PL362063A1 (en) | 2000-12-13 | 2001-12-11 | Method for in vitro culture of ovarian follicles |
JP2002549835A JP2004514458A (en) | 2000-12-13 | 2001-12-11 | In vitro culture method of follicle |
AU2002224669A AU2002224669B2 (en) | 2000-12-13 | 2001-12-11 | Method for in vitro culture of ovarian follicles |
IL15637501A IL156375A0 (en) | 2000-12-13 | 2001-12-11 | Method for in vitro culture of ovarian follicles |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00870300.1 | 2000-12-13 | ||
EP00870300A EP1215280A1 (en) | 2000-12-13 | 2000-12-13 | Method for in vitro culture of ovarian follicles |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002048316A1 true WO2002048316A1 (en) | 2002-06-20 |
Family
ID=8175874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BE2001/000209 WO2002048316A1 (en) | 2000-12-12 | 2001-12-11 | Method for in vitro culture of ovarian follicles |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040053407A1 (en) |
EP (2) | EP1215280A1 (en) |
JP (1) | JP2004514458A (en) |
KR (1) | KR20030081350A (en) |
CN (2) | CN1916165A (en) |
AT (1) | ATE408668T1 (en) |
AU (2) | AU2002224669B2 (en) |
CA (1) | CA2429401A1 (en) |
CZ (1) | CZ20031607A3 (en) |
DE (1) | DE60135869D1 (en) |
DK (1) | DK1341901T3 (en) |
HU (1) | HUP0302600A3 (en) |
IL (1) | IL156375A0 (en) |
NZ (1) | NZ525925A (en) |
PL (1) | PL362063A1 (en) |
RU (1) | RU2286384C2 (en) |
WO (1) | WO2002048316A1 (en) |
ZA (1) | ZA200303864B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006039604A1 (en) * | 2004-09-30 | 2006-04-13 | Applied Research Systems Ars Holding, N.V. | Use of pregnancy specific glycoprotein for maturation of oocytes |
KR100793680B1 (en) | 2006-09-15 | 2008-01-10 | 재단법인서울대학교산학협력재단 | Novel oil-free embryo culturing system |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006039592A1 (en) * | 2004-09-30 | 2006-04-13 | Applied Research Systems Ars Holding N.V. | Use of il-17- for maturation of oocytes |
WO2007008521A1 (en) * | 2005-07-07 | 2007-01-18 | Lonnie Shea | Stage specific follicle maturation systems |
US20070207542A1 (en) * | 2006-03-03 | 2007-09-06 | Russell Alan J | Manipulation of oxygen tension during in vitro follicle culture |
CN100999724B (en) * | 2007-01-08 | 2011-04-20 | 安徽省立医院 | Feeder cells using in immature ovocyte in-vitro cultivating maturation |
CN100999723B (en) * | 2007-01-08 | 2011-08-31 | 安徽省立医院 | In-vitro cultivating maturation process of immaturation ovocyte through promoting discharging separating or obtained by sucking in ovarian tissue |
CN100999722B (en) * | 2007-01-08 | 2011-08-03 | 安徽省立医院 | In-vitro cultivating matural process of immatural ovocyte in ovarium organized block |
ES2863580T3 (en) * | 2015-03-26 | 2021-10-11 | Nippon Suisan Kaisha Ltd | Marine fish ovaries maintenance method, culture medium adjustment method, and marine fish egg or fertilized egg production method |
KR101788968B1 (en) * | 2016-04-14 | 2017-10-23 | 서울대학교산학협력단 | Method for multi-follicle culture using Angiotensin Ⅱ receptor agonist |
RU2707252C1 (en) * | 2018-08-02 | 2019-11-25 | общество с ограниченной ответственностью "АРТ БиоВет" | Method for cattle oocyte freezing |
CN109852533B (en) * | 2019-04-02 | 2022-02-25 | 泰山医学院 | High-efficiency oocyte separation and collection device for animal ovary |
CN110129402B (en) * | 2019-04-15 | 2023-08-01 | 宁夏医科大学 | Method for researching influence of Rho-ROCK signal channel inhibitor Y27632 on mouse follicle in-vitro development |
CN112980773B (en) * | 2021-03-15 | 2023-11-17 | 中山大学附属第六医院 | Method for in vitro culture of mouse secondary follicles |
CN113462635A (en) * | 2021-07-27 | 2021-10-01 | 河北农业大学 | Method for separating, culturing and identifying sheep ovarian granulosa cells |
KR102690765B1 (en) * | 2021-12-16 | 2024-08-05 | 고려대학교 산학협력단 | Composition for cryopreservating ovarian comprising Klotho protein and N-acetylcysteine |
WO2024024742A1 (en) * | 2022-07-25 | 2024-02-01 | 国立大学法人京都大学 | In vitro culturing method for inducing ovarian follicles from fetal ovarian cells of primate |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4987080A (en) * | 1987-11-03 | 1991-01-22 | Grob Howard S | Method for in vitro maturation of oocytes |
-
2000
- 2000-12-13 EP EP00870300A patent/EP1215280A1/en not_active Withdrawn
-
2001
- 2001-12-11 CA CA002429401A patent/CA2429401A1/en not_active Abandoned
- 2001-12-11 JP JP2002549835A patent/JP2004514458A/en active Pending
- 2001-12-11 WO PCT/BE2001/000209 patent/WO2002048316A1/en active IP Right Grant
- 2001-12-11 HU HU0302600A patent/HUP0302600A3/en unknown
- 2001-12-11 US US10/450,695 patent/US20040053407A1/en not_active Abandoned
- 2001-12-11 AU AU2002224669A patent/AU2002224669B2/en not_active Ceased
- 2001-12-11 KR KR10-2003-7007959A patent/KR20030081350A/en not_active Application Discontinuation
- 2001-12-11 CZ CZ20031607A patent/CZ20031607A3/en unknown
- 2001-12-11 CN CNA2006100908040A patent/CN1916165A/en active Pending
- 2001-12-11 RU RU2003118422/13A patent/RU2286384C2/en not_active IP Right Cessation
- 2001-12-11 DE DE60135869T patent/DE60135869D1/en not_active Expired - Lifetime
- 2001-12-11 EP EP01994564A patent/EP1341901B8/en not_active Expired - Lifetime
- 2001-12-11 CN CNB018205755A patent/CN100489089C/en not_active Expired - Fee Related
- 2001-12-11 DK DK01994564T patent/DK1341901T3/en active
- 2001-12-11 PL PL01362063A patent/PL362063A1/en not_active Application Discontinuation
- 2001-12-11 AU AU2466902A patent/AU2466902A/en active Pending
- 2001-12-11 NZ NZ525925A patent/NZ525925A/en unknown
- 2001-12-11 IL IL15637501A patent/IL156375A0/en unknown
- 2001-12-11 AT AT01994564T patent/ATE408668T1/en not_active IP Right Cessation
-
2003
- 2003-05-19 ZA ZA200303864A patent/ZA200303864B/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4987080A (en) * | 1987-11-03 | 1991-01-22 | Grob Howard S | Method for in vitro maturation of oocytes |
Non-Patent Citations (5)
Title |
---|
CORTVRINDT R ET AL: "In-vitro maturation, fertilization and embryo development of immature oocytes from early preantral follicles from prepuberal mice in a simplified culture system.", HUMAN REPRODUCTION (OXFORD), vol. 11, no. 12, 1996, pages 2656 - 2666, XP001024487, ISSN: 0268-1161 * |
PICTON HELEN M ET AL: "In vitro growth of human primordial follicles from frozen-banked ovarian tissue.", MOLECULAR AND CELLULAR ENDOCRINOLOGY, vol. 166, no. 1, 15 August 2000 (2000-08-15), pages 27 - 35, XP002178183, ISSN: 0303-7207 * |
SMITZ J ET AL: "Improving in vitro maturation of oocytes in the human taking lessons from experiences in animal species.", REPRODUCTION IN DOMESTIC ANIMALS, vol. 36, no. 1, February 2001 (2001-02-01), pages 11 - 17, XP001073505, ISSN: 0936-6768 * |
SMITZ J ET AL: "OOCYTE IN-VITRO MATURATION AND FOLLICLE CULTURE: CURRENT CLINICAL ACHIEVEMENTS AND FUTURE DIRECTIONS", HUMAN REPRODUCTION, IRL PRESS, OXFORD, GB, vol. 14, no. SUPPL 1, 1999, pages 145 - 161, XP002901118, ISSN: 0268-1161 * |
SMITZ JOHAN ET AL: "Follicle culture after ovarian cryostorage.", MATURITAS, vol. 30, no. 2, 12 October 1998 (1998-10-12), pages 171 - 179, XP001024462, ISSN: 0378-5122 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006039604A1 (en) * | 2004-09-30 | 2006-04-13 | Applied Research Systems Ars Holding, N.V. | Use of pregnancy specific glycoprotein for maturation of oocytes |
KR100793680B1 (en) | 2006-09-15 | 2008-01-10 | 재단법인서울대학교산학협력재단 | Novel oil-free embryo culturing system |
Also Published As
Publication number | Publication date |
---|---|
IL156375A0 (en) | 2004-01-04 |
US20040053407A1 (en) | 2004-03-18 |
CA2429401A1 (en) | 2002-06-20 |
HUP0302600A2 (en) | 2003-11-28 |
RU2286384C2 (en) | 2006-10-27 |
EP1341901B8 (en) | 2008-12-24 |
AU2466902A (en) | 2002-06-24 |
AU2002224669B2 (en) | 2007-02-01 |
EP1341901A1 (en) | 2003-09-10 |
JP2004514458A (en) | 2004-05-20 |
KR20030081350A (en) | 2003-10-17 |
ATE408668T1 (en) | 2008-10-15 |
CN1916165A (en) | 2007-02-21 |
NZ525925A (en) | 2005-12-23 |
DE60135869D1 (en) | 2008-10-30 |
HUP0302600A3 (en) | 2004-10-28 |
CN1481437A (en) | 2004-03-10 |
EP1215280A1 (en) | 2002-06-19 |
ZA200303864B (en) | 2004-04-05 |
DK1341901T3 (en) | 2009-01-26 |
CZ20031607A3 (en) | 2003-11-12 |
EP1341901B1 (en) | 2008-09-17 |
CN100489089C (en) | 2009-05-20 |
PL362063A1 (en) | 2004-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1341901B8 (en) | Method for in vitro culture of ovarian follicles | |
Paramio et al. | Recent advances in in vitro embryo production in small ruminants | |
Telfer et al. | Ovarian follicle culture: advances and challenges for human and nonhuman primates | |
Bongso et al. | Improved quality of human embryos when co-cultured with human ampullary cells | |
AU2002224669A1 (en) | Method for in vitro culture of ovarian follicles | |
Hartshorne | In vitro culture of ovarian follicles | |
Izquierdo et al. | Effect of culture media on embryo development from prepubertal goat IVM-IVF oocytes | |
Coticchio et al. | Human oocyte maturation in vitro | |
Herta et al. | In vitro follicle culture in the context of IVF | |
Kautz et al. | Expression of genes involved in the embryo–maternal interaction in the early-pregnant canine uterus | |
Lee et al. | Synergistic effect of alanine and glycine on bovine embryos cultured in a chemically defined medium and amino acid uptake by in vitro-produced bovine morulae and blastocysts | |
Zhang et al. | Extracorporeal development and ultrarapid freezing of human fetal ova | |
Sato et al. | Meiotic maturation of bovine oocytes in vitro: improvement of meiotic competence by dibutyryl cyclic adenosine 3′, 5′-monophosphate. | |
Gosden et al. | The biology and technology of follicular oocyte development in vitro | |
Otoi et al. | Influence of maturation culture period on the development of canine oocytes after in vitro maturation and fertilization | |
Huntriss | Growth and maturation of oocytes in vitro | |
Veiga et al. | Use of co-culture of human embryos on Vero cells to improve clinical implantation rate | |
Malenko et al. | A new simple and reliable vitrification device based on Hollow Fiber Vitrification (HFV) method evaluated using IVP bovine embryos | |
Nagano et al. | Effect of duration of in vitro maturation on nuclear maturation and fertilizability of feline oocytes | |
Okada et al. | Development of pig embryos after electro-activation and in vitro fertilization in PZM-3 or PZM supplemented with fetal bovine serum | |
Osaki et al. | Fertilization of bovine oocytes grown in vitro | |
Albertini et al. | Ovarian follicle culture systems for mammals | |
Pasquariello et al. | Use of Assisted Reproductive Technologies (ARTs) to shorten generational interval in ruminants: current status and perspectives | |
Carrell et al. | Ovarian folliculogenesis: emerging role of in vitro maturation of oocytes and follicles in clinical practice | |
Gardner et al. | Introduction to the in vitro fertilization laboratory: management of sperm, oocytes, and embryos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 525925 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/03864 Country of ref document: ZA Ref document number: 200303864 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2429401 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002224669 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001994564 Country of ref document: EP Ref document number: 00875/DELNP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2003-1607 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 156375 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002549835 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018205755 Country of ref document: CN Ref document number: 1020037007959 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref country code: RU Ref document number: RU A |
|
WWP | Wipo information: published in national office |
Ref document number: 2001994564 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10450695 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037007959 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV2003-1607 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 525925 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002224669 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001994564 Country of ref document: EP |